Variant report

Variant	nsv902354
Chromosome Location	chr14:104613478-104662533
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:68)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:2)

No data

(count:68 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr14:104643343..104645021-chr14:104648909..104651142,2	K562	blood:
2	chr14:104650176..104652362-chr14:104808842..104810389,2	MCF-7	breast:
3	chr14:104649570..104650550-chr3:64449241..64449782,2	MCF-7	breast:
4	chr14:104633441..104636247-chr14:104642417..104644360,2	MCF-7	breast:
5	chr14:104617307..104621301-chr14:104625637..104628605,3	MCF-7	breast:
6	chr14:104654038..104657382-chr14:104659420..104664106,7	MCF-7	breast:
7	chr14:104632447..104634396-chr14:104650392..104653194,2	K562	blood:
8	chr14:104652967..104655075-chr14:105050050..105051684,2	MCF-7	breast:
9	chr14:104648128..104650382-chr14:104654649..104656553,2	K562	blood:
10	chr14:104612474..104614678-chr14:104620921..104622623,2	MCF-7	breast:
11	chr14:104642506..104644837-chr14:105146981..105148729,2	MCF-7	breast:
12	chr14:104644824..104647219-chr14:104651116..104653195,2	K562	blood:
13	chr14:104654764..104655392-chr14:104812527..104813058,2	MCF-7	breast:
14	chr14:104627113..104628867-chr14:104628876..104631765,2	MCF-7	breast:
15	chr14:104637508..104640421-chr14:104649656..104651711,3	MCF-7	breast:
16	chr14:104646912..104648600-chr14:104679599..104681696,2	MCF-7	breast:
17	chr14:104644824..104647219-chr14:104651116..104653195,2	K562	blood:
18	chr14:104625626..104628004-chr14:104636602..104638636,2	MCF-7	breast:
19	chr14:104637580..104639264-chr14:104654137..104656969,2	MCF-7	breast:
20	chr14:104644034..104647829-chr14:104648059..104652639,5	MCF-7	breast:
21	chr14:104630677..104633176-chr14:104635103..104637236,2	MCF-7	breast:
22	chr14:104620973..104623022-chr14:104627568..104629644,2	MCF-7	breast:
23	chr14:104636638..104639934-chr14:104644485..104647895,3	MCF-7	breast:
24	chr14:104630276..104632688-chr14:104639185..104641198,2	MCF-7	breast:
25	chr14:104648873..104651309-chr14:104652979..104655035,2	MCF-7	breast:
26	chr14:104627021..104629659-chr14:104644533..104646486,2	MCF-7	breast:
27	chr14:104633441..104636247-chr14:104642417..104644360,2	MCF-7	breast:
28	chr14:104634157..104636948-chr14:104811497..104813606,2	MCF-7	breast:
29	chr14:104602083..104606800-chr14:104649678..104656936,9	MCF-7	breast:
30	chr14:104630677..104633176-chr14:104635103..104637236,2	MCF-7	breast:
31	chr14:104648873..104651309-chr14:104652979..104655035,2	MCF-7	breast:
32	chr14:104627021..104629659-chr14:104644533..104646486,2	MCF-7	breast:
33	chr14:104617307..104621301-chr14:104625637..104628605,3	MCF-7	breast:
34	chr14:104612474..104614678-chr14:104620921..104622623,2	MCF-7	breast:
35	chr14:104627113..104628867-chr14:104628876..104631765,2	MCF-7	breast:
36	chr14:104649230..104653061-chr14:104657794..104660199,5	MCF-7	breast:
37	chr14:104611975..104614306-chr14:104614594..104616592,2	MCF-7	breast:
38	chr14:104603737..104606003-chr14:104636716..104639612,2	MCF-7	breast:
39	chr14:104622500..104624420-chr14:104650489..104652508,2	K562	blood:
40	chr14:104622500..104624420-chr14:104650489..104652508,2	K562	blood:
41	chr14:104641001..104643795-chr14:104659198..104661496,2	MCF-7	breast:
42	chr14:104625626..104628004-chr14:104636602..104638636,2	MCF-7	breast:
43	chr14:104655728..104658058-chr14:104665902..104667845,2	MCF-7	breast:
44	chr14:104583342..104586162-chr14:104646219..104648449,2	MCF-7	breast:
45	chr14:104654038..104657382-chr14:104659420..104664106,7	MCF-7	breast:
46	chr14:104651259..104651765-chr14:104760560..104761404,2	MCF-7	breast:
47	chr14:104611975..104614306-chr14:104614594..104616592,2	MCF-7	breast:
48	chr14:104617545..104619541-chr14:104760413..104762032,2	MCF-7	breast:
49	chr14:104603834..104608266-chr14:104611469..104617292,9	MCF-7	breast:
50	chr14:104637815..104640571-chr14:104677890..104680782,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ASPG-3	chr14:104630226-104630291	l_1077_chr14:104630225-104633148_lung
2	lnc-ASPG-3	chr14:104630871-104631102	l_1077_chr14:104630225-104633148_lung
3	lnc-ASPG-3	chr14:104632922-104633148	l_1077_chr14:104630225-104633148_lung
4	lnc-ASPG-3	chr14:104632709-104632824	l_1077_chr14:104630225-104633148_lung

No data

(count:2 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	KIF26A	hsa-miR-124-3p	chr14:104646343-104646364
2	KIF26A	hsa-miR-124-3p	chr14:104646357-104646363

Variant related genes	Relation type
ENSG00000207568	chromatin interactions
ENSG00000258748	chromatin interactions
ENSG00000166183	chromatin interactions
ENSG00000256050	chromatin interactions
ENSG00000066735	chromatin interactions

Extended variants
information (count: 2886 )
Associated
traits (count: 98 )

Variant overlapped rSNPs/rCNVs (count:2886 , 50 per page) page: 1 2 3 4 5 6 7 ... 58

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4906421	chr14:104613478-104613479	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs567024127	chr14:104613491-104613492	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs552143575	chr14:104613492-104613493	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs146586968	chr14:104613526-104613527	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs72714969	chr14:104613532-104613533	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs187857832	chr14:104613585-104613586	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs538219008	chr14:104613597-104613598	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs193166382	chr14:104613663-104613664	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs574868835	chr14:104613708-104613709	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs540281701	chr14:104613771-104613772	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs371070452	chr14:104613797-104613798	Weak transcription Enhancers Bivalent Enhancer Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs560233661	chr14:104613842-104613843	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs576592240	chr14:104613845-104613846	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs545625251	chr14:104613891-104613892	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs149784270	chr14:104613934-104613935	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs531553403	chr14:104613940-104613941	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs548158503	chr14:104613954-104613955	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs561483399	chr14:104613957-104613958	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs547852898	chr14:104613971-104613972	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs184364596	chr14:104614040-104614041	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs570577620	chr14:104614055-104614056	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs539219614	chr14:104614056-104614057	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs552527493	chr14:104614064-104614065	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs569533296	chr14:104614109-104614110	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs567923178	chr14:104614142-104614143	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs538198884	chr14:104614162-104614163	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs61997636	chr14:104614163-104614164	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs552713819	chr14:104614168-104614169	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs533945684	chr14:104614171-104614172	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs188047578	chr14:104614211-104614212	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs192465510	chr14:104614215-104614216	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs545590332	chr14:104614224-104614225	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs183885688	chr14:104614284-104614285	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs116374614	chr14:104614289-104614290	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs541713528	chr14:104614319-104614320	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs562038137	chr14:104614341-104614342	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs527245852	chr14:104614379-104614380	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs145703755	chr14:104614449-104614450	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs188361209	chr14:104614485-104614486	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs368344761	chr14:104614496-104614497	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs533110228	chr14:104614501-104614502	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs370450786	chr14:104614532-104614533	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs547396043	chr14:104614580-104614581	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs139748220	chr14:104614588-104614589	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs372244570	chr14:104614590-104614591	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs570714130	chr14:104614591-104614592	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs148905080	chr14:104614611-104614612	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs569314131	chr14:104614723-104614724	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs531952226	chr14:104614724-104614725	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs368331933	chr14:104614750-104614751	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:98)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Chronic myeloid leukemia	20724749	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16774939	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Neuroblastoma	18923191	CNVD
Barrett''s syndrome	19417022	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
cataract	16735990	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Cancer	20164920	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	19435499	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	20139093	CNVD
Hepatocellular carcinoma	16750200	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Glioblastoma multiforme	21922591	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	22174824	CNVD
Non-small cell lung cancer	18320023	CNVD
Melanoma	17363583	CNVD
Prostate cancer	18632612	CNVD
Congenital heart defect	22367666	CNVD
Developmental delay	22367666	CNVD
Genitourinary abnormalities	22367666	CNVD
Intellectual disability	22367666	CNVD
Microcephaly	22367666	CNVD
Muscularhypotonia	22367666	CNVD
Ocular coloboma	22367666	CNVD
Teratozoospermia	22367666	CNVD
Cervical cancer	21062161	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21990379	CNVD
Breast cancer	16417655	CNVD
22q11 deletion syndrome	22511897	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Schizophrenia	21399695	CNVD
Intracranial ependymoma	16609018	CNVD
Lung adenocarcinoma	17086460	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
14q deletion syndrome	22511897	CNVD
Epilepsy	22083797	CNVD
Urothelial carcinoma	21177765	CNVD
Ovarian cancer	21720365	CNVD
Cancer	17440070	CNVD
Neurocytoma	17123091	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Central neurocytomas	17123091	CNVD
Acute lymphoblastic leukemia	17315016	CNVD
Lung cancer	17086460	CNVD
Mortal	21835882	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	17426248	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:861 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:104605800-104615400	Weak transcription	Gastric	stomach
2	chr14:104606000-104613800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr14:104606400-104615200	Weak transcription	Left Ventricle	heart
4	chr14:104606800-104614000	Weak transcription	Colonic Mucosa	Colon
5	chr14:104606800-104615400	Weak transcription	Right Atrium	heart
6	chr14:104607000-104613600	Weak transcription	HUES48 Cell Line	embryonic stem cell
7	chr14:104607000-104613800	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr14:104607000-104614200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
9	chr14:104607000-104614400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr14:104607000-104614400	Weak transcription	HUES64 Cell Line	embryonic stem cell
11	chr14:104607000-104616200	Weak transcription	H9 Cell Line	embryonic stem cell
12	chr14:104607200-104614200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr14:104607400-104613800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
14	chr14:104607800-104613600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr14:104609200-104615800	Weak transcription	Placenta Amnion	Placenta Amnion
16	chr14:104609800-104615200	Weak transcription	Fetal Intestine Small	intestine
17	chr14:104610400-104618000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
18	chr14:104610600-104617600	Enhancers	Spleen	Spleen
19	chr14:104611400-104617000	Enhancers	Brain Germinal Matrix	brain
20	chr14:104611400-104619200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
21	chr14:104611600-104614200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
22	chr14:104611600-104618000	Enhancers	H1 Cell Line	embryonic stem cell
23	chr14:104612000-104613600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr14:104612000-104613600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr14:104612000-104618000	Enhancers	Fetal Muscle Leg	muscle
26	chr14:104612000-104619600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
27	chr14:104612200-104617200	Enhancers	Fetal Stomach	stomach
28	chr14:104612400-104616800	Enhancers	Fetal Brain Male	brain
29	chr14:104612600-104614600	Enhancers	Adipose Nuclei	Adipose
30	chr14:104612600-104615400	Weak transcription	Fetal Brain Female	brain
31	chr14:104612600-104619800	Weak transcription	Sigmoid Colon	Sigmoid Colon
32	chr14:104612800-104614400	Enhancers	Lung	lung
33	chr14:104613200-104613600	Genic enhancers	Right Ventricle	heart
34	chr14:104613400-104613800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
35	chr14:104613400-104614000	Enhancers	Placenta	Placenta
36	chr14:104613400-104614400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
37	chr14:104613400-104614600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
38	chr14:104613400-104615800	Enhancers	HUES6 Cell Line	embryonic stem cell
39	chr14:104613400-104617600	Enhancers	Fetal Lung	lung
40	chr14:104613600-104613800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
41	chr14:104613600-104613800	Bivalent Enhancer	Brain Hippocampus Middle	brain
42	chr14:104613600-104614000	Enhancers	Pancreas	Pancrea
43	chr14:104613600-104614600	Enhancers	Right Ventricle	heart
44	chr14:104613600-104616000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr14:104613600-104616200	Enhancers	HUES48 Cell Line	embryonic stem cell
46	chr14:104613600-104618000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr14:104613600-104619200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
48	chr14:104613800-104614800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
49	chr14:104613800-104616800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr14:104613800-104617400	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links